2023-08-01 2024-07-31 false Capium Accounts Production 1.1 09136732 2023-08-01 2024-07-31 09136732 bus:AbridgedAccounts 2023-08-01 2024-07-31 09136732 bus:FRS102 2023-08-01 2024-07-31 09136732 bus:AuditExemptWithAccountantsReport 2023-08-01 2024-07-31 09136732 bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 09136732 bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 09136732 2023-08-01 2024-07-31 09136732 2024-07-31 09136732 bus:RegisteredOffice 2023-08-01 2024-07-31 09136732 core:WithinOneYear 2024-07-31 09136732 core:AfterOneYear 2024-07-31 09136732 1 2023-08-01 2024-07-31 09136732 bus:Director1 2023-08-01 2024-07-31 09136732 bus:Director1 2024-07-31 09136732 bus:Director1 2022-08-01 2023-07-31 09136732 bus:Director2 2023-08-01 2024-07-31 09136732 bus:Director2 2024-07-31 09136732 bus:Director2 2022-08-01 2023-07-31 09136732 2022-08-01 09136732 bus:LeadAgentIfApplicable 2023-08-01 2024-07-31 09136732 2022-08-01 2023-07-31 09136732 2023-07-31 09136732 core:WithinOneYear 2023-07-31 09136732 core:AfterOneYear 2023-07-31 09136732 bus:EntityAccountantsOrAuditors 2022-08-01 2023-07-31 09136732 bus:OrdinaryShareClass1 2023-08-01 2024-07-31 09136732 bus:OrdinaryShareClass1 2024-07-31 09136732 bus:OrdinaryShareClass1 2022-08-01 2023-07-31 09136732 bus:OrdinaryShareClass1 2023-07-31 09136732 core:FurnitureFittings 2023-08-01 2024-07-31 09136732 core:FurnitureFittings 2024-07-31 09136732 core:FurnitureFittings 2023-07-31 09136732 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-07-31 09136732 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-07-31 09136732 core:CostValuation core:Non-currentFinancialInstruments 2024-07-31 09136732 core:CostValuation core:Non-currentFinancialInstruments 2023-07-31 09136732 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-07-31 09136732 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-07-31 09136732 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-07-31 09136732 core:Non-currentFinancialInstruments 2024-07-31 09136732 core:Non-currentFinancialInstruments 2023-07-31 09136732 core:ShareCapital 2024-07-31 09136732 core:ShareCapital 2023-07-31 09136732 core:RetainedEarningsAccumulatedLosses 2024-07-31 09136732 core:RetainedEarningsAccumulatedLosses 2023-07-31 09136732 dpl:Item1 2023-08-01 09136732 dpl:Item1 2024-07-31 09136732 dpl:Item1 2022-08-01 09136732 dpl:Item1 2023-07-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 09136732
England and Wales

 

 

 

BLISS MEDICAL CHOICE LTD


Abridged Accounts
 


Period of accounts

Start date: 01 August 2023

End date: 31 July 2024
Report to the directors on the preparation of the unaudited statutory accounts of BLISS MEDICAL CHOICE LTD for the year ended 31 July 2024
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of BLISS MEDICAL CHOICE LTD for the year ended 31 July 2024 which comprise of the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the companys accounting records and from information and explanations you have given us
As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at
http://rulebook.accaglobal.com/
This report is made solely to the Board of Directors of BLISS MEDICAL CHOICE LTD, as a body, in accordance with the terms of our engagement letter dated 17 March 2025 Our work has been undertaken solely to prepare for your approval the accounts of BLISS MEDICAL CHOICE LTD and state those matters that we have agreed to state to the Board of Directors of BLISS MEDICAL CHOICE LTD, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/factsheet163. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than BLISS MEDICAL CHOICE LTD and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that BLISS MEDICAL CHOICE LTD has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of BLISS MEDICAL CHOICE LTD. You consider that BLISS MEDICAL CHOICE LTD is exempt from the statutory audit requirement for the year
We have not been instructed to carry out an audit or a review of the accounts of BLISS MEDICAL CHOICE LTD. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts
31 July 2024



....................................................
LIGHTHALL CONSULT LTD
UNIT 128 FIRST FLOOR
415 HIGH STREET
LONDON
E15 4QZ
17 March 2025
1
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 3 526    1,278 
526    1,278 
Current assets      
Debtors: amounts falling due within one year 5,704    3,749 
Cash at bank and in hand 20,063    5,273 
25,767    9,022 
Creditors: amount falling due within one year (5,873)   (876)
Net current assets 19,894    8,146 
 
Total assets less current liabilities 20,420    9,424 
Creditors: amount falling due after more than one year (1)  
Net assets 20,419    9,424 
 

Capital and reserves
     
Called up share capital 4 100    100 
Profit and loss account 20,319    9,324 
Shareholders' funds 20,419    9,424 
 


For the year ended 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the board of directors on 17 March 2025 and were signed on its behalf by:


-------------------------------
Iyabo Titilola AKINSOLA
Director
2
General Information
BLISS MEDICAL CHOICE LTD is a private company, limited by shares, registered in England and Wales, registration number 09136732, registration address 48 DUNCROFT, PLUMSTEAD LONDON, SE18 2JA.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation was provided for and was charged on the profit realised by the company as the company qualifies as a small company
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Fixtures and Fittings 4 Straight Line
2.

Average number of employees

Average number of employees during the year was 0 (2023 : 0).
3.

Tangible fixed assets

Cost or valuation Fixtures and Fittings   Total
  £   £
At 01 August 2023 3,009    3,009 
Additions  
Disposals  
At 31 July 2024 3,009    3,009 
Depreciation
At 01 August 2023 1,731    1,731 
Charge for year 752    752 
On disposals  
At 31 July 2024 2,483    2,483 
Net book values
Closing balance as at 31 July 2024 526    526 
Opening balance as at 01 August 2023 1,278    1,278 


4.

Share Capital

Authorised
100 Class A shares of £1.00 each
Allotted, called up and fully paid
2024
£
  2023
£
100 Class A shares of £1.00 each 100    100 
100    100 

3